(Q39029483)

8 September 2017

title

Punicalagin inhibits inflammation in LPS-induced RAW264.7 macrophages via the suppression of TLR4-mediated MAPKs and NF-κB activation (English)

1 reference

8 September 2017

0 references

0 references

Xiaolong Xu

1

1 reference

8 September 2017

Peng Yin

2

1 reference

8 September 2017

Changrong Wan

3

1 reference

8 September 2017

Xinlu Chong

4

1 reference

8 September 2017

Mingjiang Liu

5

1 reference

8 September 2017

Peng Cheng

6

1 reference

8 September 2017

Jiajia Chen

7

1 reference

8 September 2017

Fenghua Liu

8

1 reference

8 September 2017

Jianqin Xu

9

1 reference

8 September 2017

publication date

1 June 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

37

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

956-965

1 reference

Points of control in inflammation

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Yuwen02f1 suppresses LPS-induced endotoxemia and adjuvant-induced arthritis primarily through blockade of ROS formation, NFkB and MAPK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Nuclear factor-kappaB as a therapeutic target in critical care medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Monocytes: subsets, origins, fates and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Toll-like receptors in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Toll-like receptors in the induction of the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Schisantherin A exhibits anti-inflammatory properties by down-regulating NF-kappaB and MAPK signaling pathways in lipopolysaccharide-treated RAW 264.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Anti-proliferative activity and protection against oxidative DNA damage by punicalagin isolated from pomegranate husk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Intestinal anti-inflammatory activity of ellagic acid in the acute and chronic dextrane sulfate sodium models of mice colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Studies of medicinal plants of Sri Lanka. Part 14: Toxicity of some traditional medicinal herbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Role of selected Indian plants in management of type 2 diabetes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Immune-suppressive activity of punicalagin via inhibition of NFAT activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Inhibitory effects of polyphenol punicalagin on type-II collagen degradation in vitro and inflammation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Macrophages and inflammatory mediators in tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Role of nitric oxide in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Pistacia chinensis inhibits NO production and upregulates HO-1 induction via PI-3K/Akt pathway in LPS stimulated macrophage cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Capillarisin inhibits iNOS, COX-2 expression, and proinflammatory cytokines in LPS-induced RAW 264.7 macrophages via the suppression of ERK, JNK, and NF-κB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Cyclooxygenase-2: a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Cyclooxygenases and prostaglandins: shaping up the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Aggravation of inflammatory bowel disease by cyclooxygenase-2 inhibitors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Anti-inflammatory activity of gumiganghwaltang through the inhibition of nuclear factor-kappa B activation in peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-κB in arsenite-induced cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Epigallocatechin-3-gallate regulates cell growth, cell cycle and phosphorylated nuclear factor-κB in human dermal fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Chitosan oligosaccharides suppress LPS-induced IL-8 expression in human umbilical vein endothelial cells through blockade of p38 and Akt protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

The protective action of ketanserin against lipopolysaccharide-induced shock in mice is mediated by inhibiting inducible NO synthase expression via the MEK/ERK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1beta by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

NF-κB, inflammation, and metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Differential release of mast cell mediators and the pathogenesis of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-9816-2

Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24473904

12 December 2020

inferred from PubMed ID database lookup

Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24473904

12 December 2020

inferred from PubMed ID database lookup

Increased oxidative stress is responsible for severer cerebral infarction in stroke-prone spontaneously hypertensive rats.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24473904

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10753-014-9816-2

1 reference

release_bt5ln7he25e53gdhopccyndxcq

8 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bt5ln7he25e53gdhopccyndxcq

24 November 2022

mapped directly with Wikidata item

1 reference